Inquiry
Tell us about your condition. Speak with our medical advisors — no obligation.
Mesenchymal stem cells targeting the spinal cord, daily rehabilitation rebuilding what was lost. See documented outcomes from past SMA patients.
Since 2005, we have been developing comprehensive protocols regarding stem cell treatment for Spinal Muscular Atrophy (SMA) to overcome the limitations of conventional therapies. In our protocols, mesenchymal stem cells (MSCs) are combined with specialized therapies for spinal muscular atrophy that not only focus on helping the patient to cope with their symptoms, but also treat the direct cause of the symptoms by promoting the healing of the injury in the spinal cord. We believe that our comprehensive stem cell treatment for spinal muscular atrophy gives our patients the best chances of improvements, allowing for a better quality of life. Different types of spinal muscular atrophy can be considered for treatment such as SMA type 1, SMA type 2, SMA type 3 (Kugelberg-Welander syndrome) and more.
Mesenchymal stem cells secrete growth factors, cytokines, and extracellular vesicles that stimulate tissue repair and modulate the immune response, promoting regeneration and reducing inflammation.
When administered to SMA patients, MSCs have been shown to promote the regeneration of damaged motor neurons and improve muscle function. In addition, MSCs can help reduce inflammation and improve the immune response, which can further aid in the repair of damaged tissues. Overall, stem cell therapy has the potential to provide a safe and effective treatment option for SMA patients.
Reagan was clinically diagnosed with SMA at 6 months after extensive genetic testing due to delayed motor function and and overall delay in hitting infant milestones was noticed. In some cases, Spinal Muscular Atrophy can be fatal. Due to Reagan’s stem cell treatments she remains cognizant and aware of her surroundings. Reagan is in fantastic health at the moment. She has continued to gain motor and oral functions over the past 2 years resulting in increased ability to feed herself, be potty trained on a special toilet, and sit in a normal chair with the aid of a back brace.
Watch more videosSpeak with our medical experts today to learn more about our specialized stem cell protocols.
Get StartedThe purpose of our treatment for spinal muscular atrophy is to promote the healing of the injury in the spinal cord in order to restore neurological function. Thus, various kinds of improvement are possible after our treatment and our past patients have experienced the following*:
Outcome data is temporarily unavailable.
Since 2005, we have been developing and optimizing our stem cell treatment protocols for various conditions. We believe that only a comprehensive treatment solution can allow our patients to truly benefit from stem cells. That is why besides providing large quantities of stem cells to maximize the regenerative potential of each patient, we also find it necessary to accompany the treatment with an extensive and daily therapy program to stimulate the regenerative response.
Our stem cell treatment for Spinal Muscular Atrophy (SMA) consist of 4 to 8 simple and minimally invasive injections of umbilical cord derived stem cells. The stem cells are transplanted using two separate methods: by intravenous way using a standard IV drip system, and through intrathecal injection performed after lumbar puncture. These two delivery methods allow for increased efficacy while ensuring safety and minimum inconvenience for the patient.
From your first inquiry to post-treatment follow-up —
we guide you every step of the way.
Tell us about your condition. Speak with our medical advisors — no obligation.
Our doctors review your medical records and recommend a tailored protocol.
Receive specialized stem cell therapy at our partner hospital, fully supervised.
We stay in touch and monitor your progress for the months that follow.
No obligation. We’ll review your situation and respond within 48 hours.
Reviewed by the Beike medical advisory team — answering patient inquiries since 2005.